Published 2022 | Version v1
Journal article

[177Lu]Lu-DOTATATE peptide receptor radionuclide therapy-associated myeloid neoplasms. Insights from the WHO pharmacovigilance database

  • 1. INSERM U1237, PhIND, Institut Blood and Brain @ Caen-Normandie, Centre Cyceron, Normandie Université, UNICAEN, 14000, Caen (France)
  • 2. Department of Pharmacy, CHU de Caen Normandie, Normandie Université, UNICAEN, 14000, Caen (France)
  • 3. Department of Nuclear Medicine, CHU de Caen Normandie, Normandie Université, UNICAEN, Avenue de La Côte de Nacre, CS 30001, 14033 Caen CEDEX 9, Caen (France)
  • 4. Pharmacoepidemiology Unit, Department of Pharmacology, Pharmacovigilance Regional Center, Caen University Hospital, Caen (France)
  • 5. Department of Hepato-Gastroenterology and Nutrition, Caen University Hospital, 14000, Caen (France)
  • 6. Department of Pharmacology, Caen University Hospital, INSERM U1086 ANTICIPE, Normandie University, UNICAEN, Caen (France)

Description

no abstract available

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-022-05833-6

Additional details

Identifiers

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
49
Journal Issue
10
Journal Page Range
p. 3332-3333
ISSN
1619-7070
CODEN
EJNMA6